Towards Healthcare

Electron Brachytherapy Companies, Innovation and Product Evolution

Date : 30 September 2025

Top Companies in the Electron Brachytherapy Market

Electron Brachytherapy Market Companies

  • Xoft (iCAD, Inc.)
  • Carl Zeiss Meditec AG
  • Elekta AB
  • Varian Medical Systems (Siemens Healthineers)
  • IntraOp Medical Corporation
  • Isoray Medical
  • Eckert & Ziegler BEBIG
  • Sensus Healthcare
  • BEBIG Medical
  • Hologic Inc.
  • ViewRay Inc.
  • Zeiss Group
  • Theragenics Corporation
  • Best Medical International
  • Mevion Medical Systems
  • RadiantBMT
  • C4 Imaging
  • IBA Group
  • RefleXion Medical
  • Accuray Inc.

Market Growth

The global electron brachytherapy market size is calculated at US$ 451.36 million in 2024, grew to US$ 494.33 million in 2025, and is projected to reach around US$ 1121.66 million by 2034. The market is expanding at a CAGR of 9.52% between 2025 and 2034.

Government awareness programs: Governments are taking initiatives to create awareness about radiotherapy. This will ensure more and more people will get access to radiotherapy.

  • In September 2025, to commemorate World radiation Awareness Day 2025 on September 7, AXREM, the UK trade group that represents providers of healthcare IT, radiation, and diagnostic medical imaging, today unveiled a new visual document called "The Radiotherapy Puzzle." The paper offers a concise, understandable summary of the diverse array of technology, infrastructure, and knowledge that collectively allow for the safe, efficient, and contemporary delivery of radiation treatment for cancer patients throughout the United Kingdom.
  • In October 2024, the government has agreed a £70 million investment in new radiation treatment equipment, following four years of relentless lobbying by radiation UK and our amazing supporters.

Electron Brachytherapy Market Value Chain Analysis

R&D

Miniaturised X-ray sources, customised applicators for different body parts, sophisticated imaging and treatment planning software, clinical trials to prove safety and effectiveness, and patient follow-up procedures and long-term results for various cancer types, including skin and breast cancer, are all part of the research and development of electron brachytherapy.

Clinical Trials and Regulatory Approvals

Clinical studies for Electron Brachytherapy (EBT) include phases to examine safety and efficacy, need clearance from the Institutional Review Board (IRB), and attempt to establish evidence for new delivery technologies and applications, such as for gynaecological and skin malignancies. This study results led to regulatory clearances, which guarantee that the EBT system and its use fulfil stringent requirements for patient care and device performance prior to broad clinical use.

Patient Support and Services

Providing post-treatment care, such as managing side effects and potential activity restrictions, obtaining consent, explaining the procedure, providing post-treatment instructions, including displaying a treatment information card for radiation monitoring and offering advice regarding contact with pregnant women or children, and ensuring patient comfort with sedation if necessary are all examples of patient support for electron brachytherapy.

Latest Announcements by Industry Leaders

In April 2024, according to Prof. Frank Verhaegen, chairman of Maastro's Physics Research Division, an invention like a novel brachytherapy applicator will only be valuable if radiation oncologists can utilise it in as many clinics as feasible. We have years of experience with Varian equipment and applicators, and it takes specialised knowledge to turn this concept into a commercially viable applicator that satisfies legal criteria and can be produced in large quantities.

Recent Developments in the Electron Brachytherapy Market

  • In June 2024, AIIMS Nagpur is pleased to announce the opening of its state-of-the-art brachytherapy facility, which will further expand its oncological service offerings. With this new addition, comprehensive radiation oncology care is now available under one roof for more than 90% of cancer patients, who usually need radiotherapy.
  • In April 2024, Elekta, a radiation therapy business, has teamed up with GE HealthCare to create new software that would enhance the experience of physicians and allow for more precise treatment.

Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com